Dow Up 0.35% Nasdaq Down 0.02%

AVEO Pharmaceuticals, Inc. (AVEO)

-NasdaqGS
1.35 Up 0.03(2.27%) 4:00PM EDT
Prev Close:1.32
Open:1.32
Bid:1.32 x 17000
Ask:1.50 x 200
1y Target Est:1.67
Beta:0.31
Next Earnings Date:N/A
Day's Range:1.32 - 1.39
52wk Range:1.00 - 2.36
Volume:536,255
Avg Vol (3m):1,124,130
Market Cap:69.74M
P/E (ttm):N/A
EPS (ttm):-1.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AVEOUp 2.27%69.74M
AMGNDown 0.26%100.78B
PFEDown 0.17%183.19B
RHHBYDown 0.52%247.66B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.19
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.92
Quarterly EPS Est (Sep-14) :-0.23
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AVEO Pharmaceuticals, Inc., doing business as AVEO Oncology, a biopharmaceutical company, is engaged in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback